| Literature DB >> 25766254 |
Zhixiang Tong1, Aniruddh Solanki1, Allison Hamilos1, Oren Levy1, Kendall Wen1, Xiaolei Yin2, Jeffrey M Karp3.
Abstract
Derived from any somatic cell type and possessing unlimited self-renewal and differentiation potential, induced pluripotent stem cells (iPSCs) are poised to revolutionize stem cell biology and regenerative medicine research, bringing unprecedented opportunities for treating debilitating human diseases. To overcome the limitations associated with safety, efficiency, and scalability of traditional iPSC derivation, expansion, and differentiation protocols, biomaterials have recently been considered. Beyond addressing these limitations, the integration of biomaterials with existing iPSC culture platforms could offer additional opportunities to better probe the biology and control the behavior of iPSCs or their progeny in vitro and in vivo. Herein, we discuss the impact of biomaterials on the iPSC field, from derivation to tissue regeneration and modeling. Although still exploratory, we envision the emerging combination of biomaterials and iPSCs will be critical in the successful application of iPSCs and their progeny for research and clinical translation.Entities:
Keywords: biomaterials; disease modeling; expansion; induced pluripotent stem cells; reprogramming
Mesh:
Substances:
Year: 2015 PMID: 25766254 PMCID: PMC4406648 DOI: 10.15252/embj.201490756
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598